NCT01587417View on ClinicalTrials.gov

Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 187004 CL

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Healthy
Interventions
DRUG

Placebo to BI 187004 CL

1 single dose per subject as oral solution

DRUG

BI 187004 CL

1 single dose per subject as oral solution

Trial Locations (1)

Unknown

1307.1.1 Boehringer Ingelheim Investigational Site, Neuss

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01587417 - Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 187004 CL | Biotech Hunter | Biotech Hunter